Houston, TX USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Protein ZMYND8 Tied to Suppression of Prostate Cancer Tumor Metastasis

Lee_MinGyu_Bronto.jpg

Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
28-Jul-2016 12:00 PM EDT Add to Favorites

Genetic Cause of 15 Percent of Colorectal Cancer Diagnoses Identified

You_Bronto.jpg

Up to 15 percent of colorectal cancers show a genetic mutation known as DNA mismatch repair deficiency, or dMMR. Until now, little has been known about how the mutation behaves in rectal cancer patients, what causes dMMR, and which treatments may be...
18-Jul-2016 3:05 PM EDT Add to Favorites

MD Anderson, NASA and ILC Dover Partner on Space Suit Art Project to Increase Childhood Cancer Awareness

Suit1withFlag_Bronto.jpg

Today, several of Space City’s best-known institutions — The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration (NASA) and ILC Dover — announced a partnership that brings the benefits of arts and...
8-Jul-2016 3:05 PM EDT Add to Favorites

Hitachi Chemical Co., Ltd. And MD Anderson Enter Into Strategic Alliance

Reuben_Bronto.jpg

Hitachi Chemical Co., Ltd. and The University of Texas MD Anderson Cancer Center have entered into a four-year strategic alliance funded by Hitachi to help develop and evaluate the company’s Micro Cavity Array (MCA) Circulating Tumor Cell (CTC)...
27-Jun-2016 10:05 AM EDT Add to Favorites

Novel Gene-Hunting Method Implicates New Culprit in Pancreatic Cancer

Draetta_Bronto.jpg

Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice, researchers have identified a new potential target for pancreatic cancer treatment, published online in Cell...
23-Jun-2016 11:05 AM EDT Add to Favorites

MD Anderson to Host a National Cancer Moonshot Summit Event June 29

The University of Texas MD Anderson Cancer Center will join institutions across the country in the inaugural national Cancer Moonshot Summit, convened at the request of Vice President Joe Biden, on June 29.
21-Jun-2016 9:05 AM EDT Add to Favorites

Shorter Radiation Course Recommended for Early-Stage Breast Cancer Patients

B_Smith_bronto.jpg

Early-stage breast cancer patients receiving a shorter course of whole breast radiation with higher radiation doses per fraction reported equivalent cosmetic, functional and pain outcomes over time as those receiving a longer, lower-dose per...
15-Jun-2016 9:05 AM EDT Add to Favorites

Antibody-Based Drug Helps “Bridge” Leukemia Patients to Curative Treatment

Kantarjian_Bronto.jpg

In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell...
10-Jun-2016 2:05 PM EDT Add to Favorites

Our Experts on Newswise

Can Gender Play a Role in Determining Cancer Treatment Choices?

Liang_H_Bronto.jpg

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

MD Anderson Study Reveals New Insight Into Tumor Progression

ZhiminLu.jpg

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

Lee_M.jpg

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

204929_Chhatwal_Jjpg.jpg

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

The HPV Vaccine: What Have We Learned?

Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
12-Jan-2010 3:45 PM EST

Our YouTube Videos